In evaluating the in vivo efficacy of CD34 Apt-coupled anti-IL-6R microspheres, a TAO model was established, and CD34 Apt-modified anti-IL-6R MS showed significant therapeutic effects on TAO mice. Here, IL6R is linked to thromboangiitis obliterans.